Physician profile
Timothy Fishman
NPI 1083933618
$19,428.64
in general payments reported to CMS, 2019-2025
31 companies · $673 in 2025
The $673 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,072 · 2020: $3,221 · 2021: $1,782 · 2022: $2,208 · 2023: $4,517 · 2024: $5,955 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,420 · Food and Beverage: $4,140 · Travel and Lodging: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,420.05 |
| Food and Beverage | $4,139.61 |
| Travel and Lodging | $585.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $11,964.79 | 2019-2024 | Affinity, Affinity, Puraply Wound Matrix |
| Smith+Nephew, INC. | $1,561.57 | 2019-2025 | Renasys Touch, Pico, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $1,184.68 | 2020-2025 | Nuzyra |
| Stryker Corporation | $769.40 | 2019-2024 | Sonicanchor, Dart-Fire, Metal Hemi |
| Kci USA, INC. | $765.17 | 2019-2023 | V.A.C. Veraflo, V.A.C. Dermatac, Prevena |
| Treace Medical Concepts, INC. | $554.23 | 2024-2025 | |
| Integra Lifesciences Corporation | $282.20 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Misonix INC | $266.67 | 2020-2021 | |
| Bioventus LLC | $193.11 | 2019-2023 | |
| Advanced Oxygen Therapy INC. | $190.20 | 2022-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Seapearl East, INC | $186.39 | 2020-2023 | |
| Tactile Systems Technology INC | $167.04 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Horizon Therapeutics Plc | $162.95 | 2021-2022 | |
| Kerecis Limited | $159.95 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Lifenet Health | $159.87 | 2023-2024 | Theragenesis Wound Matrix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $139.91 | 2021 | |
| Bone Support INC. | $128.96 | 2025 | Cerament G, Ceramentbone Void Filler |
| Averitas Pharma INC. | $109.01 | 2023-2024 | Qutenza |
| Merck Sharp & Dohme LLC | $94.57 | 2019 | |
| Ets Wound Care LLC | $81.29 | 2024 | Mirragen Advanced Wound Matrix |
| Hydrofera LLC | $59.58 | 2023-2024 | Hydrofera Blue, Cutimed Sorbion |
| Medtronic, INC. | $42.31 | 2022-2023 | Intellis Adaptivestim |
| Solventum Corporation | $37.30 | 2024 | Promogran Prisma, Activ.A.C., V.A.C.Ulta |
| Mimedx Group, INC. | $31.85 | 2025 | |
| Nalu Medical, INC. | $26.49 | 2022 | |
| Reprise Biomedical, INC. | $26.45 | 2024 | Miro3d |
| Abbvie INC. | $23.13 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $20.15 | 2022 | |
| Next Science LLC | $16.13 | 2023 | Surgx, Blastx, Xperience |
| Tei Medical INC. | $14.55 | 2019 | |
| Heron Therapeutics, INC. | $8.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.